by Spoke Blog Admin | Oct 31, 2025 | Clinical Trials
Clinical trials play a vital role in advancing medicine, offering new hope to patients with chronic conditions such as Crohn’s disease and ulcerative colitis. Every medication, infusion, and biologic therapy available today was once tested in a clinical trial....
by Spoke Blog Admin | Sep 15, 2025 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Living with Crohn’s disease or ulcerative colitis (UC) – the two main types of inflammatory bowel disease (IBD) – can be challenging, unpredictable, and exhausting. Between flare-ups, strict medication schedules, and lifestyle adjustments, patients often feel like...
by Spoke Blog Admin | Aug 20, 2025 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Introduction Inflammatory Bowel Disease (IBD) is an umbrella term primarily used to describe two chronic conditions: Crohn’s disease and ulcerative colitis. Both diseases involve inflammation of the digestive tract, but they affect different regions and layers...
by Spoke Blog Admin | May 15, 2025 | Clinical Trials
For those living with Inflammatory Bowel Disease (IBD)—a group of conditions that includes Crohn’s disease and ulcerative colitis—life is a daily battle. These chronic autoimmune diseases cause inflammation in the digestive tract, leading to symptoms such as...
by Spoke Blog Admin | Apr 15, 2025 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Living with Inflammatory Bowel Disease (IBD)—which includes Crohn’s disease and ulcerative colitis—can be an overwhelming journey. From unpredictable flare-ups and dietary restrictions to fatigue and emotional stress, IBD affects far more than just the digestive...
by Spoke Blog Admin | Mar 15, 2025 | Clinical Trials, Crohns Disease, Ulcerative Colitis
As winter approaches and the days grow colder and shorter, it’s common for our routines—and our health habits—to change. Comfort foods become more tempting, outdoor activities may decline, and our immune system works harder to fend off seasonal illnesses. What many...